Baxter pumps E75m into Ireland:
This article was originally published in Clinica
Executive Summary
Baxter International has unveiled plans to invest E75m ($110m) over a six-year period to enhance its existing operations in Ireland. With the support of the country's industrial development agency (IDA Ireland), the company will use the money to introduce new medical manufacturing technologies, upgrade its facilities and provide extensive re-training of its existing workforce. Baxter has two manufacturing facilities in the country: the Castlebar plant produces continuous ambulatory peritoneal dialysis systems and intravenous medical solutions, while the Swinford facility manufactures a range of medical accessories for renal therapy. The firm, which has over 1,000 employees in Ireland, also has a sales and marketing operation based in Dublin.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.